INTELLIGENT BIO SOLUTIONS INC.

Public companies file this within four business days when something important happens that investors should know about before the next quarterly report.

INTELLIGENT BIO SOLUTIONS INC. filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. 1 Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission Study designed to validate accuracy and real-world workplace performance of the Intelligent Fingerprinting Drug Screening System Company expects to complete enrollment and data collection by the end of July, 2026 NEW YORK, June 02, 2026 – Intelligent Bio…